Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study - Wikidata - awgldk - TriplyDB

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study

http://www.wikidata.org/entity/Q35127974

about

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing Pediatric AML: From Biology to Clinical Management Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation.Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.Cellular intrinsic mechanism affecting the outcome of AML treated with Ara-C in a syngeneic mouse model.Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.Development of treatment and clinical results in childhood acute myeloid leukemia in Poland.Prognostic Significance of Mixed-Lineage Leukemia (MLL) Gene Detected by Real-Time Fluorescence Quantitative PCR Assay in Acute Myeloid Leukemia.Pediatric acute myeloid leukemia.How I treat paediatric relapsed acute myeloid leukaemia.A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome.Trisomy 8 in pediatric acute myeloid leukemia: A NOPHO-AML study.Relapsed acute myeloblastic leukemia: first pediatric randomized study.The applicability of the WHO classification in paediatric AML. A NOPHO-AML study.11q23 abnormalities in adult Chinese patients with hematological malignancies.Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up study.Reemergence of translocation t(11;19)(q23;p13.1) in the absence of clinically overt leukemia.The Partial Duplication of the 5' Segment of KMT2A Revealed KMT2A-MLLT10 Rearrangement in a Boy with Acute Myeloid Leukemia.Congenital acute lymphoblastic leukemia case with a novel t(2:4:11) (p21:q21:q23) translocation.Translokationen des MLL-Gens

P2860

Q24612248-2E017B72-9BDB-4312-8A2D-C4A6F2FF0668 Q26799773-EC9B704F-475D-4E63-84FB-CE6D6451719E Q34273628-9388CF6F-2921-4945-B87E-A63F4BFD4289 Q35040531-18BD80CC-E7C6-4AE8-AF16-B8A597016F35 Q35331086-18331154-5AA5-40C1-A9DD-C4F8E7DB70AB Q35651744-EDE078AD-8142-4B49-971E-5C24F3054F6C Q36736376-20E471D8-3D20-42EB-A89C-7F4E36E1713C Q37234433-25A5C8C7-5723-4FF6-AE18-9ED027257A5C Q37988570-6841E7B1-6DE2-49B1-A2FF-E6A13FEFB1C2 Q38212509-722EFC5C-A126-4776-8A05-E11601280ECC Q39028173-682D7685-8CCF-4F7D-9C2C-2FEF24135CF9 Q39788816-22D681F2-B0A0-48D8-9557-F70793445505 Q40033160-06EC7110-32C3-4E53-B79A-F6C5B79D7271 Q41144841-B1462A76-5D22-4522-AC18-71DC71E51FBC Q43471137-43744A28-F8F6-4C16-A30C-A668BD4354A1 Q45388674-553CB65E-A090-437C-BB93-79CF7BD7D5F6 Q47712615-02187684-8F95-4F2A-A54A-789B51DD11DC Q50223859-A1F640EA-37EA-4FAC-8ED8-9B0B29AE1949 Q54538463-5C00E789-9435-472D-B5E4-8A0E4EB366D4 Q58492911-BDF579A7-396E-4441-A1FE-FC53FD7D4D82

P2860

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study

http://www.wikidata.org/entity/Q35127974

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Prognostic significance of add ...... ults of an international study

@ast

Prognostic significance of add ...... ults of an international study

@en

type

label

Prognostic significance of add ...... ults of an international study

@ast

Prognostic significance of add ...... ults of an international study

@en

prefLabel

Prognostic significance of add ...... ults of an international study

@ast

Prognostic significance of add ...... ults of an international study

@en

P1433

Q35127974-C8055247-1188-4DDD-A3AB-3E43A76B44E7

P1476

Q35127974-572D94B2-0628-4703-B0FF-80B92816201D

P2093

Q35127974-01192DFD-7F18-4773-82D2-1C8861FA7884

Q35127974-03A48227-EFAD-455E-871F-4F51FD608D4F

Q35127974-06FE4884-3B77-49AC-9421-C450C9154138

Q35127974-12908816-E60F-4B73-81FC-82CFC271D321

Q35127974-1CA74691-A27E-4216-AB57-3095DB76E96E

Q35127974-24700AB2-3286-4C54-BBF1-73EC19F16E93

Q35127974-26278EC0-D4F0-404B-9E00-D4768D0DB8D7

Q35127974-4B709BC3-36FF-441D-81DA-5A691CA91707

Q35127974-511FC2EA-F394-4D52-B5D6-EC37B38E991A

Q35127974-5E7FA5E4-0FEB-4A77-B1DE-DDBB38AC3CAB

P2860

Q35127974-14509715-1CC2-4292-A4E4-F556B75F162A

Q35127974-19154B46-9663-461E-BE9F-1CBC588BE73A

Q35127974-1942D1C2-04D7-436D-A1E7-21EA84A96B16

Q35127974-1B6BFEFB-E4E7-4870-A829-B62B3D280B92

Q35127974-1D2DF00C-1C48-46E2-9D0A-FC6157535C50

Q35127974-252EF259-ACCC-4ECE-B7A0-5097E2FA2493

Q35127974-28CE3198-16DF-424D-8905-9487DF4C2AFA

Q35127974-2E385D37-080A-47B1-A8A3-B8887A72466B

Q35127974-3A70BC31-B3EF-46F6-9BB3-A8E9D33FA742

Q35127974-3EE4AB4E-4FDA-401B-B2EC-76E5C45B6FBF

P304

Q35127974-A3AB65D6-30F9-4E26-9CB7-277A3B174AD4

P31

Q35127974-96914D2B-7C0E-4045-B2BD-76330850F58F

P356

Q35127974-A522008F-0DFC-4C13-BFED-051BCB464E7E

P407

Q35127974-779ACCCE-2EEB-41DD-9350-65B3CA8648E3

P433

Q35127974-457E55AF-C2D1-47F5-B5D1-7C1D7300B594

P478

Q35127974-9435A643-CEFE-40E3-9A82-7F2CC484A923

P50

Q35127974-6431F620-F348-49A0-AD00-CA382A719E0B

Q35127974-6D68E7B9-B154-47BA-9703-8A83976B84E2

Q35127974-9B7AC707-0F56-4D17-A454-F700CB12ABC6

Q35127974-B8E20E70-3735-4D57-84E7-3188223CD638

Q35127974-C2648B4F-12E2-471B-88E2-9A5433690647

Q35127974-DC9EECDE-97D0-4CBE-8E8B-ABB527C6472C

Q35127974-FF4A4232-57C7-45D6-8049-636BE2A36B23

P577

Q35127974-EC3C488F-29F9-4463-9A1E-DE8B9DF8F4D8

P5875

Q35127974-B7724CBA-4E10-48CF-8B9C-97588942D4A2

P698

Q35127974-2BC67A9D-0477-4102-B261-1E31F373FA97

P932

Q35127974-0476029A-B498-4E55-90A1-86CB5D752AE9

P356

BLOOD-2010-12-328302

P1433

P1476

Prognostic significance of add ...... ults of an international study

@en

P2093

Akira Morimoto

http://www.w3.org/2001/XMLSchema#string

Anna Leszl

http://www.w3.org/2001/XMLSchema#string

Anne Auvrignon

http://www.w3.org/2001/XMLSchema#string

Brenda Gibson

http://www.w3.org/2001/XMLSchema#string

C Michel Zwaan

http://www.w3.org/2001/XMLSchema#string

Christine Perot

http://www.w3.org/2001/XMLSchema#string

David Webb

http://www.w3.org/2001/XMLSchema#string

Dirk Reinhardt

http://www.w3.org/2001/XMLSchema#string

Erik Forestier

http://www.w3.org/2001/XMLSchema#string

Eva A Coenen

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.

DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia.

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

t(7;12)(q36;p13) and t(7;12)(q32;p13)--translocations involving ETV6 in children 18 months of age or younger with myeloid disorders.

Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia

CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins.

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.

P304

7102-7111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2010-12-328302

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Daisuke Tomizawa

Christine J Harrison

Zuzana Zemanová

Jeffrey Rubnitz

P577

2011-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51106602

http://www.w3.org/2001/XMLSchema#string

P698

21551233

http://www.w3.org/2001/XMLSchema#string

P932

3143552

http://www.w3.org/2001/XMLSchema#string